OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 63 filers reported holding OVID THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,569 | -5.9% | 43,117 | -19.6% | 0.00% | – |
| Q2 2023 | $175,952 | +107.5% | 53,644 | +63.2% | 0.00% | – |
| Q1 2023 | $84,784 | +1187.3% | 32,862 | +828.0% | 0.00% | – |
| Q4 2022 | $6,586 | -78.0% | 3,541 | -78.0% | 0.00% | – |
| Q3 2022 | $30,000 | -33.3% | 16,059 | -23.1% | 0.00% | – |
| Q2 2022 | $45,000 | -25.0% | 20,871 | +9.4% | 0.00% | – |
| Q1 2022 | $60,000 | -13.0% | 19,070 | -11.2% | 0.00% | – |
| Q4 2021 | $69,000 | -54.9% | 21,465 | -52.8% | 0.00% | – |
| Q3 2021 | $153,000 | -79.4% | 45,434 | -76.1% | 0.00% | – |
| Q2 2021 | $743,000 | +136.6% | 190,200 | +144.1% | 0.00% | – |
| Q1 2021 | $314,000 | -9.5% | 77,934 | -48.1% | 0.00% | – |
| Q4 2020 | $347,000 | -53.4% | 150,113 | +15.9% | 0.00% | – |
| Q3 2020 | $744,000 | -33.2% | 129,526 | -14.2% | 0.00% | – |
| Q2 2020 | $1,113,000 | +205.8% | 150,887 | +23.6% | 0.00% | – |
| Q1 2020 | $364,000 | -74.4% | 122,061 | -64.3% | 0.00% | – |
| Q4 2019 | $1,420,000 | +639.6% | 342,176 | +477.6% | 0.00% | – |
| Q3 2019 | $192,000 | +100.0% | 59,243 | +13.8% | 0.00% | – |
| Q2 2019 | $96,000 | -57.1% | 52,074 | -58.6% | 0.00% | – |
| Q1 2019 | $224,000 | +140.9% | 125,906 | +225.6% | 0.00% | – |
| Q4 2018 | $93,000 | -68.3% | 38,668 | -25.3% | 0.00% | – |
| Q3 2018 | $293,000 | +31.4% | 51,767 | +80.6% | 0.00% | – |
| Q2 2018 | $223,000 | +13.8% | 28,662 | +3.6% | 0.00% | – |
| Q1 2018 | $196,000 | -25.8% | 27,671 | +3.8% | 0.00% | – |
| Q4 2017 | $264,000 | +347.5% | 26,657 | +286.1% | 0.00% | – |
| Q3 2017 | $59,000 | +11.3% | 6,905 | +36.5% | 0.00% | – |
| Q2 2017 | $53,000 | – | 5,057 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,006,185 | $12,860,000 | 5.90% |
| GLOBEFLEX CAPITAL L P | 2,794,834 | $8,972,000 | 0.92% |
| BVF INC/IL | 6,631,051 | $21,286,000 | 0.77% |
| EcoR1 Capital, LLC | 6,082,200 | $19,524,000 | 0.62% |
| CHI Advisors LLC | 400,000 | $1,284,000 | 0.43% |
| Ikarian Capital, LLC | 705,082 | $2,264,000 | 0.34% |
| Artal Group S.A. | 2,500,000 | $8,025,000 | 0.22% |
| DCF Advisers, LLC | 141,701 | $455,000 | 0.18% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 766,901 | $2,462,000 | 0.07% |
| ACADIAN ASSET MANAGEMENT LLC | 2,040,084 | $6,543,000 | 0.02% |